Bioabsorbable Surgical Mesh Market Seen Reaching $1.88 Billion by 2030

The bioabsorbable surgical mesh market is projected to grow from $1.25 billion in 2025 to $1.88 billion by 2030, driven by more surgeries, better absorbable polymer technology, and demand for minimally invasive options. North America led the market in 2025, while Asia-Pacific is expected to grow the fastest.

Why it matters: - Bioabsorbable surgical mesh is gaining traction as hospitals look for temporary tissue support that dissolves after healing. - The shift away from permanent implants could help lower long-term complications, infections, and revision risks in surgeries such as hernia repair and soft tissue reinforcement. - The market’s projected growth signals wider adoption of absorbable materials in surgical care.

What happened: - The bioabsorbable surgical mesh market is projected to rise from $1.25 billion in 2025 to $1.36 billion in 2026. - The market is forecast to reach $1.88 billion by 2030. - That outlook implies an 8.4% CAGR from 2026 to 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Bioabsorbable surgical mesh is a medical implant made from materials that gradually break down and are absorbed by the body. - The mesh provides temporary structural support during healing. - The product is commonly used in hernia repair and soft tissue reinforcement. - The market’s recent growth has been driven by the drawbacks of permanent surgical meshes. - Other growth factors include more hernia and soft tissue repair surgeries, greater awareness of post-surgery complications, more hospital-based surgeries, and early adoption of absorbable polymer materials. - The report points to stronger growth supported by improvements in bioabsorbable polymer technologies. - It also cites rising use of minimally invasive procedures, bioactive meshes, and drug-eluting meshes. - The report highlights growing use of composite and bioactive mesh materials. - Regional coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - The 2026 report adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - Download a free sample of the report. - View the full report.

Between the lines: - Rising surgical volumes are doing more than expanding procedure counts; they are also increasing demand for materials that reduce post-operative risk. - The emphasis on temporary implants suggests surgeons and buyers are prioritizing flexibility, recovery, and fewer long-term foreign-body issues. - North America’s lead reflects mature healthcare systems and early adoption of surgical innovation, while Asia-Pacific’s faster growth points to broader access and rising procedure volumes.

What's next: - The market will likely keep expanding as aging populations push surgical volumes higher. - Broader clinical acceptance in specialty surgeries could widen the addressable market. - Continued product development in bioactive, composite, and drug-eluting meshes may shape the next phase of competition. - Efforts to reduce infections and other post-operative complications should remain a central driver of product adoption.

The bottom line: - Bioabsorbable surgical mesh is moving from a niche option to a broader surgical support category, with growth tied to both clinical preference and rising procedure counts.